ホーム › 悪性黒色腫 › ノースカロライナ › Durham
Durham、NCにおける悪性黒色腫の臨床試験
Durhamとその周辺地域（約30マイル以内）の拠点で、悪性黒色腫に関する21件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
被験者募集中観察研究健康なボランティア歓迎
- Durham VA Medical Center, Durham
NeoAdjuvant, Spare-Adjuvant (NASA) in Stage IIIB-IV (M1a) Melanoma
被験者募集中第2相
- Lineberger Comprehensive Cancer Center, Chapel Hill · 10マイル先
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
被験者募集中第3相
- Duke Health System, Durham
Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma
被験者募集中第3相
- Duke University Medical Center, Durham
A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
被験者募集中第2相
- Local Institution - 0100, Durham
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
被験者募集中観察研究
- UNC- Chapel Hill, Chapel Hill · 10マイル先
DOC1021 Dendritic Cell Immunotherapy for Refractory Melanoma
被験者募集中第1/2相
- University of North Carolina, Chapel Hill · 10マイル先
A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
被験者募集中第1/2相
- Duke Cancer Institute, Durham
Project: Every Child for Younger Patients With Cancer
被験者募集中観察研究
- Duke University Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10マイル先
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
被験者募集中第1相
- Lineberger Comprehensive Cancer Center, Chapel Hill · 10マイル先
A Feasibility Study Utilizing Immune Recall to Increase Response to Checkpoint Therapy
被験者募集中第1相
- Duke University Medical Center, Durham
A Study to Investigate the Safety and Efficacy of IOV-3001 in Adults With Advanced Melanoma Who Will Receive Lifileucel
被験者募集中第1/2相
- UNC Hospitals, The University of North Carolina at Chapel Hill, Chapel Hill · 10マイル先
Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions
被験者募集中第1/2相
- Duke University Medical Center, Durham
IL-17 Blockade to Decrease irAEs (REPLAY)
被験者募集中第1相
- Duke University Health System, Durham
A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body
被験者募集中第1/2相
- University of North Carolina at Chapel Hill, Chapel Hill · 10マイル先
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
被験者募集中第2/3相
- Duke University Medical Center, Durham
Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients
被験者募集中第3相
- Duke University Medical Center - Duke Cancer Center, Durham
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
被験者募集中観察研究
- Massive Bio SYNERGY-AI site, Chapel Hill · 10マイル先
Excision of Lymph Node Trial (EXCILYNT) (Mel69)
被験者募集中
- Duke University Health System, Durham
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
被験者募集中
- Duke University Medical Center, Durham
- University of North Carolina at Chapel Hill, Chapel Hill · 10マイル先
- University of North Carolina Hospitals - Hillsborough Campus, Hillsborough · 13マイル先
他の都市における悪性黒色腫の試験
- Houston, TX59件の研究
- New York City, NY38件の研究
- Los Angeles, CA34件の研究
- Nashville, TN33件の研究
- Pittsburgh, PA31件の研究
- Boston, MA26件の研究
- Philadelphia, PA23件の研究
- San Francisco, CA22件の研究
- Atlanta, GA21件の研究
- St. Louis, MO21件の研究
- Salt Lake City, UT21件の研究
- Columbus, OH21件の研究
Durhamにおける他の研究
- 乳がん63件の研究
- がん（全種類）58件の研究
- 非小細胞肺癌39件の研究
- 多発性骨髄腫37件の研究
- 転移性癌33件の研究
- 急性骨髄性白血病33件の研究
- 肺がん32件の研究
- 前立腺がん32件の研究
- 大腸癌28件の研究
- 慢性リンパ性白血病27件の研究
- 卵巣がん27件の研究
- 心不全26件の研究
ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。